Literature DB >> 19124753

Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection.

Luisa Cervantes-Barragán1, Ulrich Kalinke, Roland Züst, Martin König, Boris Reizis, Constantino López-Macías, Volker Thiel, Burkhard Ludewig.   

Abstract

The swift production of type I IFNs is one of the fundamental aspects of innate immune responses against viruses. Plasmacytoid dendritic cell-derived type I IFNs are of prime importance for the initial control of highly cytopathic viruses such as the mouse hepatitis virus (MHV). The aim of this study was to determine the major target cell populations of this first wave of type I IFNs. Generation of bone marrow-chimeric mice expressing the type I IFN receptor (IFNAR) on either hemopoietic or non-bone marrow-derived cells revealed that the early control of MHV depended mainly on IFNAR expression on hemopoietic cells. To establish which cell population responds most efficiently to type I IFNs, mice conditionally deficient for the IFNAR on different leukocyte subsets were infected with MHV. This genetic analysis revealed that IFNAR expression on LysM+ macrophages and CD11c+ dendritic cells was most important for the early containment of MHV within secondary lymphoid organs and to prevent lethal liver disease. This study identifies type I IFN-mediated cross-talk between plasmacytoid dendritic cells on one side and macrophages and conventional dendritic cells on the other, as an essential cellular pathway for the control of fatal cytopathic virus infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124753     DOI: 10.4049/jimmunol.182.2.1099

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus.

Authors:  Nadine Honke; Namir Shaabani; Giuseppe Cadeddu; Ursula R Sorg; Dong-Er Zhang; Mirko Trilling; Karin Klingel; Martina Sauter; Reinhard Kandolf; Nicole Gailus; Nico van Rooijen; Christoph Burkart; Stephan E Baldus; Melanie Grusdat; Max Löhning; Hartmut Hengel; Klaus Pfeffer; Masato Tanaka; Dieter Häussinger; Mike Recher; Philipp A Lang; Karl S Lang
Journal:  Nat Immunol       Date:  2011-11-20       Impact factor: 25.606

2.  Plasmacytoid dendritic cells control T-cell response to chronic viral infection.

Authors:  Luisa Cervantes-Barragan; Kanako L Lewis; Sonja Firner; Volker Thiel; Stephanie Hugues; Walter Reith; Burkhard Ludewig; Boris Reizis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

3.  Virus-induced inflammasome activation is suppressed by prostaglandin D2/DP1 signaling.

Authors:  Rahul Vijay; Anthony R Fehr; Ann M Janowski; Jeremiah Athmer; Dorthea L Wheeler; Matthew Grunewald; Ramakrishna Sompallae; Samarchith P Kurup; David K Meyerholz; Fayyaz S Sutterwala; Shuh Narumiya; Stanley Perlman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

4.  Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.

Authors:  Yi Wang; Ying Sun; Andong Wu; Shan Xu; Ruangang Pan; Cong Zeng; Xu Jin; Xingyi Ge; Zhengli Shi; Tero Ahola; Yu Chen; Deyin Guo
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

5.  Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus.

Authors:  Ling Zhao; Kristine M Rose; Ruth Elliott; Nico Van Rooijen; Susan R Weiss
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

6.  Murine Coronavirus Cell Type Dependent Interaction with the Type I Interferon Response.

Authors:  Kristine M Rose; Susan R Weiss
Journal:  Viruses       Date:  2009-12-01       Impact factor: 5.048

7.  A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections.

Authors:  Gennady Bocharov; Roland Züst; Luisa Cervantes-Barragan; Tatyana Luzyanina; Egor Chiglintsev; Valery A Chereshnev; Volker Thiel; Burkhard Ludewig
Journal:  PLoS Pathog       Date:  2010-07-22       Impact factor: 6.823

8.  Type I interferon receptor-independent and -dependent host transcriptional responses to mouse hepatitis coronavirus infection in vivo.

Authors:  Matthijs Raaben; Marian J A Groot Koerkamp; Peter J M Rottier; Cornelis A M de Haan
Journal:  BMC Genomics       Date:  2009-08-03       Impact factor: 3.969

9.  RNase L mediated protection from virus induced demyelination.

Authors:  Derek D C Ireland; Stephen A Stohlman; David R Hinton; Parul Kapil; Robert H Silverman; Roscoe A Atkinson; Cornelia C Bergmann
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

Review 10.  Coronaviruses post-SARS: update on replication and pathogenesis.

Authors:  Stanley Perlman; Jason Netland
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.